A Christian lobbying group fighting the proposed importation of low-cost prescription drugs has received behind-the-scenes help from the drug industry, the latest example of pharmaceutical companies trying to influence Congress clandestinely.
The Traditional Values Coalition, which bills itself as a Christian advocacy group representing 43,000 churches, has mailed to the districts of several conservative House Republicans this sharply disputed warning: Legislation to allow the importation of U.S.-made pharmaceuticals from Canada and Europe might make RU-486, called the "abortion pill," as easy to get as aspirin.
The Traditional Values Coalition (TVC) portrays its campaign as a moral fight for the "sanctity of life." Documents provided to The Washington Post, however, show that drug lobbyists played a key role in crafting its argument and in disseminating the information to lawmakers. Pharmaceutical companies oppose the legislation -- which would legalize the reimportation of U.S.-made prescription drugs that sell for less in Canada than in the United States -- not over abortion but because it would erode their profits.
...
A recent TVC letter sent to Congress was signed by the coalition's executive director, Andrea Sheldon Lafferty. It was originally drafted, however, by Tony Rudy, a lobbyist for pharmaceutical companies and a former top aide to House Majority Leader Tom DeLay (R-Tex.), computer records show. Lafferty also circulated a memo -- linking the legislation to RU-486's availability -- that was drafted by Bruce Kuhlik, a senior vice president at the Pharmaceutical Research and Manufacturers of America (PhRMA), a trade group funded by the nation's biggest pharmaceutical firms.